Epidemiology of invasive fungal diseases on the basis of autopsy reports
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Invasive fungal diseases (IFDs) are a major cause of morbidity and mortality among immunocompromised patients and cost to health services. They are difficult to prevent, diagnose, and treat. This difficulty in diagnosis leads us to treat them empirically by using several tools, including epidemiological data, non-culture methods and images. Most of the available epidemiological information may not be accurate because we are dealing with a disease that only has an estimated 50% chance of being diagnosed before death. Therefore, autopsy reports become a valuable tool, not only to define the real epidemiology, but also to address the trend in pre-mortem diagnosis, which is the best marker available to prove the efficiency of the research in IFD. This article reviews and analyzes the data on IFD obtained from 11 single-center, multi-center and nationwide autopsy reports published between 2008 and 2013, and also discusses the issues we need to address in order to improve the quality of the epidemiological data on invasive fungal disease obtained from autopsy reports.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, studies of autopsy reports suggest that only 50% of invasive fungal diseases are diagnosed before death [25].”
From Estimation of Direct Healthcare Costs of Fungal Diseases in the United States (2019) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies found that only half of invasive fungal infections are diagnosed before death [38].”
From Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018 (2022) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital
Groll, A. H., Shah, P. M., Mentzel, C., Schneider, M., Just-Nuebling, G., & Huebner, K. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)92700-0 · Cited by 778 · cited 5×
“From 2008 to 2013, 11 single-center, multi-center and nationwide autopsy reports on IFD have been published worldwide in PubMed [1–6,15–19].”
BackgroundInfluentialImaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
Greene, R. E., Schlamm, H. T., Oestmann, J.-W., Stark, P., Durand, C., Lortholary, O., Wingard, J. R., Herbrecht, R., Ribaud, P., Patterson, T. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/509917 · Cited by 594
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)
Lortholary, O., Gangneux, J.-P., Sitbon, K., Lebeau, B., de Monbrison, F., Le Strat, Y., Coignard, B., Dromer, F., & Bretagne, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03548.x · Cited by 331
Lewis, R. E., Cahyame‐Zuniga, L., Leventakos, K., Chamilos, G., Ben‐Ami, R., Tamboli, P., Tarrand, J., Bodey, G. P., Luna, M., & Kontoyiannis, D. P. (2013) · Mycoses · doi:10.1111/myc.12081 · Cited by 248 · cited 9×
“Microbiological information was used for diagnosis in one study only [6].”
BackgroundMethodResultInfluentialRickerts, V., Mousset, S., Lambrecht, E., Tintelnot, K., Schwerdtfeger, R., Presterl, E., Jacobi, V., Just-Nubling, G., & Bialek, R. (2007) · Clinical Infectious Diseases · doi:10.1086/512812 · Cited by 209 · cited 1×
“The quality of data on IFD obtained from autopsy reports can certainly be improved by addressing the following issues: a) establishing standard procedures for diagnosis (pathology and microbiology or pathology and polymerase chain reaction (PCR) [20] plus clinical information); b) establishing standard inclusion crite…”
BackgroundBurden of aspergillosis-related hospitalizations in the United States
Dasbach, E. J., Davies, G. M., & Teutsch, S. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317487 · Cited by 159
Menzin, J., Meyers, J. L., Friedman, M., Perfect, J. R., Langston, A. A., Danna, R. P., & Papadopoulos, G. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080325 · Cited by 151 · cited 1×
“aspergillosis at 12 weeks of therapy [8]); d) they may require surgery; e) treatments are prolonged (from weeks to months or years); f) the delay of their treatment is associated with an increased mortality rate [9]; g) they may relapse after apparent cure if a subsequent period of immunosuppression occurs (in this ca…”
BackgroundTrends in the postmortem epidemiology of invasive fungal infections at a university hospital
Lehrnbecher, T., Frank, C., Engels, K., Kriener, S., Groll, A. H., & Schwabe, D. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.06.018 · Cited by 116 · cited 2×
“[15] Aspergillus-like** Candida NA [16] Aspergillus-like (41) Candida (36) NA**”
Sipsas, N. V., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/503844 · Cited by 92 · cited 1×
“aspergillosis at 12 weeks of therapy [8]); d) they may require surgery; e) treatments are prolonged (from weeks to months or years); f) the delay of their treatment is associated with an increased mortality rate [9]; g) they may relapse after apparent cure if a subsequent period of immunosuppression occurs (in this ca…”
BackgroundTrends in the Postmortem Diagnosis of Opportunistic Invasive Fungal Infections in Patients With AIDS
Antinori, S., Nebuloni, M., Magni, C., Fasan, M., Adorni, F., Viola, A., Corbellino, M., Galli, M., Vago, G., Parravicini, C., et al. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpraae8lz7dtne · Cited by 84 · cited 10×
“Abbreviations AIDS, acquired immunodeficiency syndrome; IFD, invasive fungal disease.”
BackgroundInfluential
Research works printed but not linked: 1
- [21]Schwarze EW Die Bedeutung der Autopsie--heute und morgen Verh Dtsch Ges Pathol 2001 85 118 31 11894389
Cited by
Estimation of Direct Healthcare Costs of Fungal Diseases in the United States
Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy776 · Cited by 438
“For example, studies of autopsy reports suggest that only 50% of invasive fungal diseases are diagnosed before death [25].”
BackgroundPrevalence and Healthcare Burden of Fungal Infections in the United States, 2018
Rayens, E., & Norris, K. A. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab593 · Cited by 228
“Previous studies found that only half of invasive fungal infections are diagnosed before death [38].”
BackgroundSchelenz, S., Barnes, R. A., Barton, R. C., Cleverley, J. R., Lucas, S. B., Kibbler, C. C., & Denning, D. W. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70006-x · Cited by 190
Johnson, M. D., Lewis, R. E., Dodds Ashley, E. S., Ostrosky-Zeichner, L., Zaoutis, T., Thompson, G. R., Andes, D. R., Walsh, T. J., Pappas, P. G., Cornely, O. A., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa394 · Cited by 172
The burden of serious human fungal infections in Brazil
Giacomazzi, J., Baethgen, L., Carneiro, L. C., Millington, M. A., Denning, D. W., Colombo, A. L., Pasqualotto, A. C., & in association with the LIFE program (2016) · Mycoses · doi:10.1111/myc.12427 · Cited by 164
Metadata
- Authors
- Dignani, M. C.
- Corresponding author
- Dignani, María Cecilia
- Venue
- F1000Prime Reports
- Publisher
- Faculty Opinions Ltd
- Published
- 2014-09-04
- Volume
- 6
- Pages
- 81-81
- ISSN
- 2051-7599 (ISSN-L)
- PMC
- PMC4166943
- OpenAlex
- W1968954779
- Semantic Scholar
- 7f3948da6d39b2c7b04d75ff6c3cf1553d88a6cd
- Cited by
- 73
- References
- 21
- Citations by year
- 2025: 9 · 2024: 6 · 2023: 2 · 2022: 11 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 5 · 2017: 4 · 2016: 8 · 2015: 5
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc
- Locations
- F1000Prime Reports (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive fungal infections, autopsy reports, epidemiology, immunocompromised patients, antemortem diagnosis, diagnostic accuracy, empirical antifungal therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology of invasive fungal diseases on the basis of autopsy reports. https://app.cochat.ai/papers/10.12703/p6-81
- The paper
- Dignani, M. C. (2014). Epidemiology of invasive fungal diseases on the basis of autopsy reports. F1000Prime Reports. https://doi.org/10.12703/p6-81
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.